Genesis IBRC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194N01016
  • NSEID:
  • BSEID: 514336
INR
98.98
-2.02 (-2.0%)
BSENSE

Mar 30

BSE+NSE Vol: 32

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 187665,
    "name": "Genesis IBRC",
    "stock_name": "Genesis IBRC",
    "full_name": "Genesis IBRC India Ltd",
    "name_url": "stocks-analysis/genesis-ibrc",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "98.98",
    "chg": -2.02,
    "chgp": "-2.0%",
    "dir": -1,
    "prev_price": "101.00",
    "mcapval": "457.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 514336,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 40,
    "indexname": "India SENSEX",
    "isin": "INE194N01016",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "32 ",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genesis-ibrc-187665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3917965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenesisIBRCIndi_mojoScore_3917965.png",
        "date": "2026-03-26 10:10:02",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with the most up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3888392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenesisIBRCIndi_mojoScore_3888392.png",
        "date": "2026-03-13 10:10:29",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Jan 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3864120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenesisIBRCIndi_mojoScore_3864120.png",
        "date": "2026-03-02 10:10:36",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3846717",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GenesisIBRCIndi_mojoScore_3846717.png",
        "date": "2026-02-19 10:10:50",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "When is the next results date for Genesis IBRC India Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-genesis-ibrc-india-ltd-3836101",
        "imagepath": "",
        "date": "2026-02-12 23:16:43",
        "description": "The next results date for Genesis IBRC India Ltd is scheduled for 14 February 2026...."
      },
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3827199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GenesisIBRCIndi_mojoScore_3827199.png",
        "date": "2026-02-08 10:10:29",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 08 February 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Genesis IBRC India Ltd Upgraded to Sell by MarketsMOJO Amid Flat Financials and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-upgraded-to-sell-by-marketsmojo-amid-flat-financials-and-valuation-concerns-3806769",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenesisIBRCIndi_mojoScore_3806769.png",
        "date": "2026-01-28 08:05:02",
        "description": "Genesis IBRC India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 27 Jan 2026, reflecting a nuanced shift in its financial and market outlook. Despite persistent challenges in profitability and valuation, certain technical and financial trend parameters have shown stabilisation, prompting a reassessment of the company’s investment appeal within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Genesis IBRC India Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-3797655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenesisIBRCIndi_mojoScore_3797655.png",
        "date": "2026-01-21 08:02:31",
        "description": "Genesis IBRC India Ltd has been downgraded from a Sell to a Strong Sell rating as of 20 Jan 2026, reflecting deteriorating technical indicators and valuation concerns despite its impressive long-term returns. The downgrade follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, signalling caution for investors amid flat recent financial performance and mixed market signals."
      },
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3783203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenesisIBRCIndi_mojoScore_3783203.png",
        "date": "2026-01-06 10:10:10",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 181,
    "sid": "187665",
    "stock_news_url": "https://www.marketsmojo.com/news/genesis-ibrc-india-187665"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Closure of trading window for the fourth quarter and financial year ended on March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "26-Mar-2026",
      "details": "Intimation for allotment of equity shares which were issued on preferential basis.",
      "source": "BSE"
    },
    {
      "caption": "The Company Has Received In-Principle Approval From BSE Limited For Issue Of Equity Shares On Preferential Basis.",
      "datetime": "13-Mar-2026",
      "details": "The Company has received in-principle approval from BSE Limited for issue of equity shares to promoters and non-promoters on preferential basis.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Closure of Trading Window

26-Mar-2026 | Source : BSE

Closure of trading window for the fourth quarter and financial year ended on March 31 2026

Announcement under Regulation 30 (LODR)-Allotment

26-Mar-2026 | Source : BSE

Intimation for allotment of equity shares which were issued on preferential basis.

The Company Has Received In-Principle Approval From BSE Limited For Issue Of Equity Shares On Preferential Basis.

13-Mar-2026 | Source : BSE

The Company has received in-principle approval from BSE Limited for issue of equity shares to promoters and non-promoters on preferential basis.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available